Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2005-09-13
2005-09-13
Priebe, Scott D. (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S354000, C435S455000, C536S023100, C536S024100
Reexamination Certificate
active
06943018
ABSTRACT:
Disclosed is a transgenic vertebrate cell containing a nucleic acid construct comprising a murine SOCS-3 promoter, or an operative fragment thereof, or an operative derivative of either of these.
REFERENCES:
patent: 4959313 (1990-09-01), Taketo
patent: 5532143 (1996-07-01), Grosveld
patent: 5547940 (1996-08-01), Nice
patent: 5610053 (1997-03-01), Chung
patent: 5720936 (1998-02-01), Wadsworth et al.
patent: 5723319 (1998-03-01), King et al.
patent: 5824838 (1998-10-01), Melmed
patent: 5849283 (1998-12-01), Ciliberto
patent: 5863529 (1999-01-01), Rodriguez
patent: WO 98/20023 (1998-05-01), None
Auernhammer, C.J. et al., “Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter”,Proc. Natl. Acad. Sci., vol. 96, pp. 6964-6969, Jun. 8, 1999.
Akita, S. et al., “Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function”,J. Clin. Endocrinol. Metab., 81(11): 4170-8, Nov. 1996, Abstract only.
Auernhammer, C.J. et al., “Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis”,Endocrinology, 139(5): 2201-8, May 1998.
Auernhammer, C.J. et al., “Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion”,Mol. Endocrinol., 12(7): 954-61, Jul. 1998.
Bousquet, C. et al., “A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy”,J. Biol. Chem., 272(16): 10551-7, Apr. 18, 1997.
Chesnokova, V. et al., “Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response”,Endocrinology, 139(5): 2209-16, May 1998.
Li, Q.L. et al., “Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected atT-20 cells overexpressing LIF”,Endocrine, 7(3): 325-30, Dec. 1997, Abstract only.
Ray, D.W. et al., “Leukemia inhibitory factor regulates proopiomelanocortin transcription”,Ann. N.Y. Acad. Sci., 840:162-73, May 1, 1998.
Ray, D.W., et al., “Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.”,J. Clin. Invest., 97(8): 1852-9, Apr. 15, 1996.
Shimon, I. et al., “Cytokine-dependent gp 130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion”,J. Clin. Invest., 100(2): 357-63, Jul. 15, 1997.
Stefana, B. et al., “Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch”,Proc. Natl. Acad. Sci. USA, 93(22): 12502-6, Oct. 29, 1996.
Wang, Z. et al., “Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface”,Endocrinology, 137(7): 2947-53, Jul. 1996.
Yano, H. et al., “Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development”,Mol. Endocrinol., 12(11): 1708-20, Nov. 1998.
Adams, T.E. et al., “Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling”,J. Biol. Chem., 273(3): 1285-7, Jan. 16, 1998, Abstract only.
Andrejko, K.M. et al., “Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat”,Am. J. Physiol., 275(6 Pt 1): G1423-9, Dec. 1998, Abstract only.
Banner, L.R. et al., “Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine”,J. Neurosci., 18(14): 5456-62, Jul. 15, 1998, Abstract only.
Bjorbaek, C. et al., “Identification of SOCS-3 as a potential mediator of central leptin resistance”,Mol. Cell., 1(4): 619-25, Mar. 1998, Abstract only.
Boeuf, H. et al., “Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells”,J. Cell Biol., 138(6): 1207-17, Sep. 22, 1997, Abstract only.
Ernst, M. et al., “Gp 130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways”,J. Biol. Chem., 271(47): 30136-43, Nov. 22, 1996, Abstract only.
Hagan, M.M. et al., “Role of the CNS Melanocortin System in the Response to Overfeeding”,J. Neurosci., 19(6): 2362-2367, Mar. 15, 1999, Abstract only.
Heinrich, P.C. et al., “Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway”,Biochem. J., 334(Pt 2): 297-314, Sep. 1, 1998, Abstract only.
Hilton, D.J. et al., “Twenty proteins containing a C-terminal SOCS box form five structural classes”,Proc. Natl. Acad. Sci. USA, 95(1): 114-9, Jan. 6, 1998, Abstract only.
Jenab, S. et al., “Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells”,Endocrinology, 139(4): 1883-90, Apr. 1998, Abstract only.
Kamura, T. et al., “The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families”,Genes Dev., 12(24): 3872-81, Dec. 15, 1998, Abstract only.
Katahira, M. et al., “Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells”,Endocrinology, 139(5): 2414-22, May 1998, Abstract only.
Kunisada, K. et al., “Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp 130 in cardiac myocytes”,Circulation, 94(10): 2626-32, Nov. 15, 1996, Abstract only.
Lecomte, M.J. et al., “Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins”,J. Neurochem., 70(3): 971-82, Mar. 1998. Abstract only.
Marti, O. et al., “Activation of the hypothalamic-pituitary axis in adrenalectomised rats: potentiation by chronic stress”,Brain Res., 821(1): 1-7, Mar. 6, 1999, Abstract only.
Nicholson, S.E. et al., “Mutational analysis of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction”,EMBO, J., 18(2): 375-85, Jan. 15, 1999, Abstract only.
Nicholson, S.E. et al., “The SOCS proteins: a new family of negative regulators of signal transduction”,J. Leukoc. Biol., 63(6): 665-68, Jun. 1998, Abstract only.
Okabe, T. et al., “Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells”,J. Endocrinol., 156(1): 169-75, Jan. 1998, Abstract only.
Piekorz, R.P. et al., “Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells”,Biochim. Biophys. Acta, 1402(3): 313-23, Apr. 24, 1998, Abstract only.
Poulin, G. et al., “NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene”,Mol. Cell Biol., 17(11): 6673-82, Nov. 1997, Abstract only.
Slominski, A. et al., “Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients”,Human Pathol., 30(2): 208-15, Feb. 1999, Abstract only.
Song, M.M. et al., “The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities”,J. Biol. Chem., 273(52): 35056-62, Dec. 25, 1998, Abstract only.
Sta
Auernhammer Christoph J.
Melmed Shlomo
Cedars-Sinai Medical Center
Davis , Wright, Tremaine, LLP
Levy Seth D.
Priebe Scott D.
LandOfFree
Transgenic expression from a SOCS-3 promoter in vertebrate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic expression from a SOCS-3 promoter in vertebrate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic expression from a SOCS-3 promoter in vertebrate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3428291